Trends in seasonal influenza vaccine distribution in the European Union: 2003-4 to 2007-8

Seasonal influenza is widely regarded as a continuing threat to public health, with vaccination remaining the principal measure of prophylaxis. In 2003, the World Health Organization issued targets for influenza vaccine coverage in the elderly of at least 50% by 2006 and 75% by 2010, endorsed by the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Euro surveillance : bulletin européen sur les maladies transmissibles 2008-10, Vol.13 (43)
1. Verfasser: Rodriguez de Azero, M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 43
container_start_page
container_title Euro surveillance : bulletin européen sur les maladies transmissibles
container_volume 13
creator Rodriguez de Azero, M
description Seasonal influenza is widely regarded as a continuing threat to public health, with vaccination remaining the principal measure of prophylaxis. In 2003, the World Health Organization issued targets for influenza vaccine coverage in the elderly of at least 50% by 2006 and 75% by 2010, endorsed by the European Parliament in two resolutions in 2005 and 2006. However, a number of European public health systems lack mechanisms to assess progress in influenza vaccine uptake. The European Vaccine Manufacturers group (EVM) undertook a Europe-wide survey of vaccine distribution over the last five seasons (between 2003 and 2008) to provide baseline data from which vaccination trends may be extrapolated. The survey data showed that the dose distribution level per capita in the 27 EU countries increased from 17% in 2003-4 to 20% in 2006-7; this growth was not maintained in the season 2007-8. Even without information on which age or risk groups received the vaccine, an immunisation rate of approximately 20% of the whole population falls short of the public health goal by more than half: an estimated 49% of the total population fall into risk groups recommended to receive the influenza vaccine in Europe. These data provide the only systematic review of vaccine dose distribution across Europe from a uniform source. Although they represent an important baseline parameter, age- and risk-group related vaccine uptake data with sufficient detail are needed to assist public health policy decision making, immunisation planning and monitoring. In light of this situation, and to support the improvement of immunisation rates across the EU, EVM aims to provide dose distribution data for each influenza season to assist Member States in the implementation of local immunisation policies.
doi_str_mv 10.2807/ese.13.43.19013-en
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69705489</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69705489</sourcerecordid><originalsourceid>FETCH-LOGICAL-c260n-2e7987fd698cd68e23e7c50be8fd64d2e31340025d2c5272fb2b830cf97e28b43</originalsourceid><addsrcrecordid>eNpNkD1PwzAYhC0EoqXwBxiQJ7YU-7UT22wIlQ-pEks7MFmO80YEpU6xEyT49aS0Ekx3Ot3d8BByydkcNFM3mHDOxVyKOTeMiwzDEZnyvGCZMlwd__MTcpbSO2NSMAOnZMK1kSoHmJLXVcRQJdoEmtClLrh29HU7YPh29NN53wSkVZP62JRD33RhV-3fkC6G2G3RBboOY3pLgTGRSdp3O6cyfU5OatcmvDjojKwfFqv7p2z58vh8f7fMPBQsZIDKaFVXhdG-KjSCQOVzVqIeM1kBCi4kY5BX4HNQUJdQasF8bRSCLqWYkev97zZ2HwOm3m6a5LFtXcBuSLYwiuVSm7EI-6KPXUoRa7uNzcbFL8uZ3QG1I1DLhZXC_gK1GMbR1eF9KDdY_U0OBMUPxDBwuA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69705489</pqid></control><display><type>article</type><title>Trends in seasonal influenza vaccine distribution in the European Union: 2003-4 to 2007-8</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Rodriguez de Azero, M</creator><creatorcontrib>Rodriguez de Azero, M ; European Vaccine Manufacturers Influenza Working Group</creatorcontrib><description>Seasonal influenza is widely regarded as a continuing threat to public health, with vaccination remaining the principal measure of prophylaxis. In 2003, the World Health Organization issued targets for influenza vaccine coverage in the elderly of at least 50% by 2006 and 75% by 2010, endorsed by the European Parliament in two resolutions in 2005 and 2006. However, a number of European public health systems lack mechanisms to assess progress in influenza vaccine uptake. The European Vaccine Manufacturers group (EVM) undertook a Europe-wide survey of vaccine distribution over the last five seasons (between 2003 and 2008) to provide baseline data from which vaccination trends may be extrapolated. The survey data showed that the dose distribution level per capita in the 27 EU countries increased from 17% in 2003-4 to 20% in 2006-7; this growth was not maintained in the season 2007-8. Even without information on which age or risk groups received the vaccine, an immunisation rate of approximately 20% of the whole population falls short of the public health goal by more than half: an estimated 49% of the total population fall into risk groups recommended to receive the influenza vaccine in Europe. These data provide the only systematic review of vaccine dose distribution across Europe from a uniform source. Although they represent an important baseline parameter, age- and risk-group related vaccine uptake data with sufficient detail are needed to assist public health policy decision making, immunisation planning and monitoring. In light of this situation, and to support the improvement of immunisation rates across the EU, EVM aims to provide dose distribution data for each influenza season to assist Member States in the implementation of local immunisation policies.</description><identifier>ISSN: 1560-7917</identifier><identifier>EISSN: 1560-7917</identifier><identifier>DOI: 10.2807/ese.13.43.19013-en</identifier><identifier>PMID: 18947522</identifier><language>eng</language><publisher>Sweden</publisher><subject>Aged ; European Union ; Female ; Health Care Surveys ; Humans ; Immunization Programs - statistics &amp; numerical data ; Immunization Programs - trends ; Influenza Vaccines - supply &amp; distribution ; Influenza, Human - prevention &amp; control ; Male ; Middle Aged ; Motivation</subject><ispartof>Euro surveillance : bulletin européen sur les maladies transmissibles, 2008-10, Vol.13 (43)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c260n-2e7987fd698cd68e23e7c50be8fd64d2e31340025d2c5272fb2b830cf97e28b43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18947522$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rodriguez de Azero, M</creatorcontrib><creatorcontrib>European Vaccine Manufacturers Influenza Working Group</creatorcontrib><title>Trends in seasonal influenza vaccine distribution in the European Union: 2003-4 to 2007-8</title><title>Euro surveillance : bulletin européen sur les maladies transmissibles</title><addtitle>Euro Surveill</addtitle><description>Seasonal influenza is widely regarded as a continuing threat to public health, with vaccination remaining the principal measure of prophylaxis. In 2003, the World Health Organization issued targets for influenza vaccine coverage in the elderly of at least 50% by 2006 and 75% by 2010, endorsed by the European Parliament in two resolutions in 2005 and 2006. However, a number of European public health systems lack mechanisms to assess progress in influenza vaccine uptake. The European Vaccine Manufacturers group (EVM) undertook a Europe-wide survey of vaccine distribution over the last five seasons (between 2003 and 2008) to provide baseline data from which vaccination trends may be extrapolated. The survey data showed that the dose distribution level per capita in the 27 EU countries increased from 17% in 2003-4 to 20% in 2006-7; this growth was not maintained in the season 2007-8. Even without information on which age or risk groups received the vaccine, an immunisation rate of approximately 20% of the whole population falls short of the public health goal by more than half: an estimated 49% of the total population fall into risk groups recommended to receive the influenza vaccine in Europe. These data provide the only systematic review of vaccine dose distribution across Europe from a uniform source. Although they represent an important baseline parameter, age- and risk-group related vaccine uptake data with sufficient detail are needed to assist public health policy decision making, immunisation planning and monitoring. In light of this situation, and to support the improvement of immunisation rates across the EU, EVM aims to provide dose distribution data for each influenza season to assist Member States in the implementation of local immunisation policies.</description><subject>Aged</subject><subject>European Union</subject><subject>Female</subject><subject>Health Care Surveys</subject><subject>Humans</subject><subject>Immunization Programs - statistics &amp; numerical data</subject><subject>Immunization Programs - trends</subject><subject>Influenza Vaccines - supply &amp; distribution</subject><subject>Influenza, Human - prevention &amp; control</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Motivation</subject><issn>1560-7917</issn><issn>1560-7917</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkD1PwzAYhC0EoqXwBxiQJ7YU-7UT22wIlQ-pEks7MFmO80YEpU6xEyT49aS0Ekx3Ot3d8BByydkcNFM3mHDOxVyKOTeMiwzDEZnyvGCZMlwd__MTcpbSO2NSMAOnZMK1kSoHmJLXVcRQJdoEmtClLrh29HU7YPh29NN53wSkVZP62JRD33RhV-3fkC6G2G3RBboOY3pLgTGRSdp3O6cyfU5OatcmvDjojKwfFqv7p2z58vh8f7fMPBQsZIDKaFVXhdG-KjSCQOVzVqIeM1kBCi4kY5BX4HNQUJdQasF8bRSCLqWYkev97zZ2HwOm3m6a5LFtXcBuSLYwiuVSm7EI-6KPXUoRa7uNzcbFL8uZ3QG1I1DLhZXC_gK1GMbR1eF9KDdY_U0OBMUPxDBwuA</recordid><startdate>20081023</startdate><enddate>20081023</enddate><creator>Rodriguez de Azero, M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20081023</creationdate><title>Trends in seasonal influenza vaccine distribution in the European Union: 2003-4 to 2007-8</title><author>Rodriguez de Azero, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c260n-2e7987fd698cd68e23e7c50be8fd64d2e31340025d2c5272fb2b830cf97e28b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Aged</topic><topic>European Union</topic><topic>Female</topic><topic>Health Care Surveys</topic><topic>Humans</topic><topic>Immunization Programs - statistics &amp; numerical data</topic><topic>Immunization Programs - trends</topic><topic>Influenza Vaccines - supply &amp; distribution</topic><topic>Influenza, Human - prevention &amp; control</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Motivation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rodriguez de Azero, M</creatorcontrib><creatorcontrib>European Vaccine Manufacturers Influenza Working Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Euro surveillance : bulletin européen sur les maladies transmissibles</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rodriguez de Azero, M</au><aucorp>European Vaccine Manufacturers Influenza Working Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trends in seasonal influenza vaccine distribution in the European Union: 2003-4 to 2007-8</atitle><jtitle>Euro surveillance : bulletin européen sur les maladies transmissibles</jtitle><addtitle>Euro Surveill</addtitle><date>2008-10-23</date><risdate>2008</risdate><volume>13</volume><issue>43</issue><issn>1560-7917</issn><eissn>1560-7917</eissn><abstract>Seasonal influenza is widely regarded as a continuing threat to public health, with vaccination remaining the principal measure of prophylaxis. In 2003, the World Health Organization issued targets for influenza vaccine coverage in the elderly of at least 50% by 2006 and 75% by 2010, endorsed by the European Parliament in two resolutions in 2005 and 2006. However, a number of European public health systems lack mechanisms to assess progress in influenza vaccine uptake. The European Vaccine Manufacturers group (EVM) undertook a Europe-wide survey of vaccine distribution over the last five seasons (between 2003 and 2008) to provide baseline data from which vaccination trends may be extrapolated. The survey data showed that the dose distribution level per capita in the 27 EU countries increased from 17% in 2003-4 to 20% in 2006-7; this growth was not maintained in the season 2007-8. Even without information on which age or risk groups received the vaccine, an immunisation rate of approximately 20% of the whole population falls short of the public health goal by more than half: an estimated 49% of the total population fall into risk groups recommended to receive the influenza vaccine in Europe. These data provide the only systematic review of vaccine dose distribution across Europe from a uniform source. Although they represent an important baseline parameter, age- and risk-group related vaccine uptake data with sufficient detail are needed to assist public health policy decision making, immunisation planning and monitoring. In light of this situation, and to support the improvement of immunisation rates across the EU, EVM aims to provide dose distribution data for each influenza season to assist Member States in the implementation of local immunisation policies.</abstract><cop>Sweden</cop><pmid>18947522</pmid><doi>10.2807/ese.13.43.19013-en</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1560-7917
ispartof Euro surveillance : bulletin européen sur les maladies transmissibles, 2008-10, Vol.13 (43)
issn 1560-7917
1560-7917
language eng
recordid cdi_proquest_miscellaneous_69705489
source MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals
subjects Aged
European Union
Female
Health Care Surveys
Humans
Immunization Programs - statistics & numerical data
Immunization Programs - trends
Influenza Vaccines - supply & distribution
Influenza, Human - prevention & control
Male
Middle Aged
Motivation
title Trends in seasonal influenza vaccine distribution in the European Union: 2003-4 to 2007-8
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T12%3A22%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trends%20in%20seasonal%20influenza%20vaccine%20distribution%20in%20the%20European%20Union:%202003-4%20to%202007-8&rft.jtitle=Euro%20surveillance%20:%20bulletin%20europ%C3%A9en%20sur%20les%20maladies%20transmissibles&rft.au=Rodriguez%20de%20Azero,%20M&rft.aucorp=European%20Vaccine%20Manufacturers%20Influenza%20Working%20Group&rft.date=2008-10-23&rft.volume=13&rft.issue=43&rft.issn=1560-7917&rft.eissn=1560-7917&rft_id=info:doi/10.2807/ese.13.43.19013-en&rft_dat=%3Cproquest_cross%3E69705489%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69705489&rft_id=info:pmid/18947522&rfr_iscdi=true